Saudi institutions are optimistic about China's "huge investment opportunities" in the fields of health care and biotechnology. Ekta Torani, chief investment officer of Saudi KBW Venture Capital Company, recently said in Abu Dhabi, United Arab Emirates that with the increasingly close economic and trade ties between the Gulf region and China, the institution is optimistic about China's "huge investment opportunities" in the fields of health care and biotechnology.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.Consumer stocks of Hong Kong stocks fell, with Budweiser Asia Pacific (01876.HK) and China Resources Beer (00291.HK) falling more than 5%, Nongfu Spring (09633.HK) and Mengniu Dairy (02319.HK) falling 4%, and Li Ning (02331.HK) and Anta Sports (02020.HK) falling more than 3%.
Defender said that Li Tie had not decided whether to appeal, and Li Tie's defender was interviewed by CCTV reporters outside the court. Regarding the first-instance judgment that Li Tie was sentenced to 20 years, the defender said that Li Tie had not decided whether to appeal, and he would negotiate with Li Tie again. Regarding the state of Li Tie's trial today, the defender's answer is: calm, peaceful and stable. (Tiantian Sports)Guangdong Electric Power A and others set up enterprise service companies with AI business. The enterprise search APP shows that recently, Guangdong Energy Group Enterprise Service Co., Ltd. was established, with the legal representative of Xu Lin and the registered capital of 150 million yuan. Its business scope includes: artificial intelligence basic resources and technology platform; Research and development of intelligent robots; Artificial intelligence industry application system integration services. Enterprise equity penetration shows that the company is jointly held by Guangdong Electric Power A and others.Huichuan Technology's newly established subsidiary contains a number of AI businesses. The enterprise search APP shows that Beijing Huichuan Technology Co., Ltd. was recently established with Guo Lipeng as the legal representative and a registered capital of 300 million yuan. Its business scope includes: artificial intelligence theory and algorithm software development; Basic resources and technical platform of artificial intelligence; General application system of artificial intelligence; Artificial intelligence application software development, etc. Enterprise investigation shows that the company is wholly owned by Huichuan Technology.
Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.SHIBOR reported 1.4040% overnight, down by 7.80 basis points. In 7 days, SHIBOR reported 1.7580%, up 12.30 basis points. SHIBOR reported 1.7350% in three months, down by 0.50 basis point.On the 13th, silver fell by 1.91%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract silver was 2,502, up or down by -1.91%, with a turnover of 1,004,900 lots. The position data showed that the top 20 seats were net, and the difference position was 30,444 lots. The total turnover of silver futures contracts was 1,505,900 lots, an increase of 417,500 lots over the previous day. The first 20 seats in the contract held 335,600 lots, a decrease of 15,200 lots from the previous day. The short positions in the top 20 seats of the contract were 251,300 lots, an increase of 17,500 lots over the previous day. (Sina Futures)
Strategy guide 12-14
Strategy guide 12-14